MRNA

CureVac's 'half-baked' COVID-flu data release questioned by analysts, but shares still rally 17%
Fierce Biotech
Sun, 01/8/23 - 10:05 pm
CureVac
GSK
MRNA
vaccines
COVID-19
clinical trials
Moderna caps off busy week with $1.2B CytomX collab to better target mRNA therapies
Fierce Biotech
Fri, 01/6/23 - 09:46 am
Moderna Therapeutics
MRNA
CytomX
Moderna/BioNTech: cancer vaccines will show mRNA not a one-trick pony
Financial Times
Mon, 01/2/23 - 06:39 pm
vaccines
Moderna Therapeutics
BioNTech
MRNA
cancer vaccines
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
BioSpace
Fri, 12/23/22 - 10:37 am
BioNTech
clinical trials
malaria
MRNA
vaccines
BNT165b1
Moderna finalizes decade-long mRNA alliance with U.K.
Medical Marketing and Media
Thu, 12/22/22 - 10:50 am
Moderna Therapeutics
UK
vaccines
MRNA
Pfizer projects mRNA vaccine sales will hover around $15B by 2030
Endpoints
Tue, 12/13/22 - 11:58 pm
Pfizer
MRNA
vaccines
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Fierce Biotech
Tue, 12/13/22 - 10:35 am
Merck
Moderna Therapeutics
MRNA
cancer immunotherapy
Keytruda
melanoma
Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)
BioSpace
Tue, 12/13/22 - 10:27 am
Gritstone Bio
MRNA
samRNA
patents
Pfizer, BioNTech strike back at Moderna with mRNA vaccine patent lawsuit
Fierce Pharma
Tue, 12/6/22 - 08:52 pm
Pfizer
Moderna Therapeutics
BioNTech
patents
legal
vaccines
COVID-19
MRNA
Experimental flu vaccine, developed using mRNA, seen as potential game changer
Stat
Sun, 11/27/22 - 07:10 pm
MRNA
vaccines
Flu
flu vaccines
mRNA drugs with a built-in ‘copy machine’ could lead to safer, more effective therapies
Stat
Fri, 11/18/22 - 10:28 am
MRNA
drug development
CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos
Fierce Biotech
Wed, 11/16/22 - 10:35 am
CureVac
vaccines
CV8102
MRNA
cancer
Daiichi Sankyo’s Covid-19 vaccine trial meets primary endpoint
Clinical Trials Arena
Tue, 11/15/22 - 10:51 am
Daiichi Sankyo
clinical trials
MRNA
vaccines
DS-5670
COVID-19
mRNA non-vaccine therapeutics field set to reach $2 billion by 2028
Clinical Trials Arena
Tue, 11/8/22 - 10:54 am
MRNA
drug development
Moderna Therapeutics
Ultragenyx
Omega Therapeutics
BioNTech
cancer
OTX-2002
CSL makes $4bn+ move in mRNA vaccines with Arcturus deal
Pharmaphorum
Wed, 11/2/22 - 10:15 am
CSL
Arcturus
vaccines
MRNA
Everest and Providence report positive Phase II data for Covid-19 vaccine
Clinical Trials Arena
Thu, 10/20/22 - 10:43 am
Everest Medicines
Providence Therapeutics
vaccines
MRNA
COVID-19
PTX-COVID19-B
After matching Comirnaty, Providence plans phase 3 booster study for COVID-19 vaccine candidate
Fierce Biotech
Wed, 10/19/22 - 10:57 am
Providence Therapeutics
COVID-19
vaccines
boosters
MRNA
Moderna says yes to Autolus, licensing targeting technology for immuno-oncology project
Fierce Biotech
Wed, 10/12/22 - 10:53 am
Moderna Therapeutics
Autolus Therapeutics
MRNA
immuno-oncology
From Africa to Australia and beyond, BioNTech's global mRNA ambitions take flight
Fierce Pharma
Fri, 10/7/22 - 10:49 am
Pfizer
BioNTech
MRNA
Australia
COVID-19
Astellas, Pantherna add organ to mRNA tie-up; Rocket launches sale of six figures worth of stock
Endpoints
Wed, 10/5/22 - 10:41 am
Astellas
Pantherna
MRNA

Pages